The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...
It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...
Hosted on MSN
The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains
In addition to API, drugs have inactive components called excipients, whose production is also global. A tariff could apply to the final drug product or its separate components. But even if the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback